Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results